Amrutanjan Health Care Ltd: From Balm to Bold — Can 130 Years of Pain Relief Juice Up the Valuation?

1. At a Glance

Born in 1893, Amrutanjan is your grandmother’s go-to balm turned FMCG underdog. With 120+ years in pain management, it now sells wellness balms, hygiene products, and fruit juices—yes, really. Despite legacy charm and profitability, growth rates are slower than a cold compress in December.

2. Introduction with Hook

If Parle-G is India’s biscuit nostalgia, Amrutanjan is its balm balm. Founded when the British still ruled, this company has survived pandemics, liberalization, and millennials ignoring balms for instant sprays. But today’s Amrutanjan isn’t just about sore backs—it’s flirting with everything from sanitary pads to fruity drinks.

• Market Cap: ₹2,079 Cr
• FY25 Revenue: ₹452 Cr
• FY25 PAT: ₹51 Cr
• FY25 OPM: 13%
• Stock P/E: 41

Is it defensive FMCG gold, or a half-dead legacy coasting on old commercials?

3. Business Model (WTF Do They Even Do?)

Three-legged stool:

1. Pain Management (Balm + Roll-on): Still the poster boy—Amrutanjan Strong, Back Pain Roll-On, Headache Balm.
2. Woman Hygiene: Be.You sanitary pads & cramp roll-ons—riding the D2C wellness wave.
3. Beverages: Frustratingly out-of-place fruit juice drinks (Fruitnik), which confuse both investors and customers.

Revenue Mix (Estimated):

• Pain Relief: ~60%
• Hygiene: ~15%
• Beverages: ~25%

Juices are high volume but low margin, while balms are steady earners. Diversification strategy or midlife crisis? You decide.

4. Financials Overview

Revenue & Profit (₹ Cr)